ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis

Detalles Bibliográficos
Autores principales: Yurttas, Can, Königsrainer, Alfred, Löffler, Markus W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
ASO Author Reflections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590993/
https://www.ncbi.nlm.nih.gov/pubmed/34117575
http://dx.doi.org/10.1245/s10434-021-10263-z
_version_ 1784599115018010624
author Yurttas, Can
Königsrainer, Alfred
Löffler, Markus W.
author_facet Yurttas, Can
Königsrainer, Alfred
Löffler, Markus W.
author_sort Yurttas, Can
collection PubMed
description
format Online
Article
Text
id pubmed-8590993
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85909932021-11-23 ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis Yurttas, Can Königsrainer, Alfred Löffler, Markus W. Ann Surg Oncol ASO Author Reflections Springer International Publishing 2021-06-11 2021 /pmc/articles/PMC8590993/ /pubmed/34117575 http://dx.doi.org/10.1245/s10434-021-10263-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle ASO Author Reflections
Yurttas, Can
Königsrainer, Alfred
Löffler, Markus W.
ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
title ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
title_full ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
title_fullStr ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
title_full_unstemmed ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
title_short ASO Author Reflections: First Do No Harm—Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis
title_sort aso author reflections: first do no harm—revisiting adjuvant hyperthermic intraperitoneal chemotherapy (hipec) trials to reduce the risk of peritoneal metastasis
topic ASO Author Reflections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590993/
https://www.ncbi.nlm.nih.gov/pubmed/34117575
http://dx.doi.org/10.1245/s10434-021-10263-z
work_keys_str_mv AT yurttascan asoauthorreflectionsfirstdonoharmrevisitingadjuvanthyperthermicintraperitonealchemotherapyhipectrialstoreducetheriskofperitonealmetastasis
AT konigsraineralfred asoauthorreflectionsfirstdonoharmrevisitingadjuvanthyperthermicintraperitonealchemotherapyhipectrialstoreducetheriskofperitonealmetastasis
AT lofflermarkusw asoauthorreflectionsfirstdonoharmrevisitingadjuvanthyperthermicintraperitonealchemotherapyhipectrialstoreducetheriskofperitonealmetastasis

Ejemplares similares